中国银河（601881）发表研报，港股资产价值重估，AI赋能驱动加速。"资金面修复+政策催化+优质标 的流入"的三重逻辑，推动港股从全球估值洼地向价值高地跃迁。同时，在全球产业链重构的背景下， 以DeepSeek为代表的国产AI正成为中国AI产业从"技术追赶"转向"行业标杆"的战略支点，中国AI产业有 望实现从技术跟随转向生态主导的关键跨越。DeepSeek的开源策略打破了传统闭源模型的技术壁垒， 以低成本高性能特性重塑全球AI价值链其引发的生态协同效应与全球化实践，或将重新定义数字时代 的产业格局。 ...

| 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告 | | --- | | 的虚假记载、误导性陈述或者重大遗漏负连带责任。 | 证券代码：601881 证券简称：中国银河 公告编号：2025-046 中国银河证券股份有限公司2024年面向专业投资者 公开发行公司债券（第一期）（品种一）（续发行） 发行结果公告 特此公告。 中国银河证券股份有限公司董事会 2025 年 6 月 21 日 中国银河证券股份有限公司（以下简称"发行人"）面向专业投资者公开 发行面值不超过 200 亿元（含 200 亿元）的公司债券已经上海证券交易所审核 同意并经中国证券监督管理委员会"证监许可〔2024〕1197 号文"注册。 根据《中国银河证券股份有限公司 2024 年面向专业投资者公开发行公司 债券（第一期）（品种一）（续发行）募集说明书》，中国银河证券股份有限 公司 2024 年面向专业投资者公开发行公司债券（第一期）（品种一）（续发 行）（以下简称"本期续发行债券"）的发行规模不超过人民币 20 亿元（含 20 亿元）。本期续发行债券期限为 3 年（起息日为 2024 年 10 月 17 日，本金 兑付日期为 ...

债券代码：149537.SZ 债券简称：21天马01 中国银河证券股份有限公司关于 天马微电子股份有限公司董事长、总经理 变更的临时受托管理事务报告 债券受托管理人 声 明 本报告依据《公司债券发行与交易管理办法》《公司债券受托管理人执业 行为准则》及《天马微电子股份有限公司2019年面向合格投资者公开发行公司 债券债券受托管理协议》（以下简称"《债券受托管理协议》"）等相关文 件，以及天马微电子股份有限公司（以下简称"发行人"或"公司"）披露的 相关公告，由"天马微电子股份有限公司2021年面向合格投资者公开发行公司 债券（第一期）（以下简称"21天马01"）"的债券受托管理人中国银河证券 股份有限公司（以下简称"中国银河证券"）编制。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相 关事宜作出独立判断，而不应将本报告中的任何内容据以作为中国银河证券所 作的承诺或声明。 根据天马微电子股份有限公司于 2025 年 6 月 13 日披露的《天马微电子股 份有限公司关于公司董事长、总经理离任暨选举董事长的公告》《天马微电子 股份有限公司第十届董事会第三十一次会议决议公告》，发行人董事长、总经 ...

Core Viewpoint - The investment outlook for the home appliance sector is driven by the stability of company performance, increasing dividend rates, and the upward trend in valuations due to declining risk-free interest rates [1] Industry Review - The home appliance industry is expected to achieve absolute and relative returns in 2023 and 2024, with the SW home appliance index rising by 3.8%, 25.40%, and 1.939% for the years 2023, 2024, and 2025 YTD respectively [1] - Domestic sales benefit from the durable necessity of major appliances and the competitive landscape, with the market also receiving a boost from the old-for-new subsidy policy since Q4 2024 [1] - The global market is benefiting from China's competitive advantage in the home appliance sector, leading to an increase in global market share and penetration in emerging markets [1] - Leading companies in the home appliance sector are steadily increasing their dividend rates, while the decline in China's risk-free interest rates is driving up valuations for these leading firms [2] Industry Outlook - Short-term pressures exist in the industry, with domestic sales potentially experiencing demand exhaustion due to the lack of seamless integration of national subsidies, and intensified competition in the online air conditioning market [2] - Concerns remain regarding U.S. tariff risks and potential negative impacts on the global economy [2] - The industry's certainty stems from its global competitive advantages and the ability to navigate U.S. tariff risks through a globally integrated supply chain, with no significant loss of U.S. customers reported [2] - The durable necessity of major appliances underpins long-term domestic demand stability, and the decline in China's risk-free interest rates is expected to continue driving up valuations for high-dividend leading companies [2] Expectations for Subsidy Policies - Consumer goods are expected to benefit from long-term special government bonds of 150 billion and 300 billion yuan in 2024 and 2025 respectively, with the number of appliance categories benefiting from subsidies expanding from 8 to 12 by 2025 [3] - The current subsidy amount is anticipated to support the market until early Q3, with provinces likely to adopt varying policies to extend the subsidy period [3] - The most benefited appliances from subsidies are air conditioners and cleaning appliances, leading to intense competition in the online market to capture current subsidy benefits [3] New Supply Landscape Overseas - U.S. tariff policy risks since April 2025 have negatively impacted exports, although a phased agreement reached in Geneva in May has alleviated some export pressures [4] - According to customs statistics, China's home appliance exports are expected to grow by 3.8% and 14.1% in 2023 and 2024 respectively, with air conditioner exports significantly exceeding expectations in 2024 [4] - Exports are projected to decline starting April 2025, with production output for air conditioners showing a year-on-year decrease from May to August [4] - Only industry leaders are establishing overseas supply chains, leading to a higher concentration of demand orders in the U.S. market by 2026, while smaller companies are likely to be absent [4]

Market Overview - A-shares experienced a low open and high close, with the Shanghai Composite Index rising by 0.35%, Shenzhen Component Index by 0.41%, and ChiNext Index by 0.66% [1] - The total market turnover reached 12,435 billion, with over 3,500 stocks in the market closing in the green [1] Stablecoin Concept - The stablecoin concept surged throughout the day, with the digital currency sector rising by 4.72%, making it the top-performing industry concept [2] - Notable stocks included Tianyang Technology and Sifang Jingchuang hitting the 20% limit up, while Lakala rose over 15% [2] - The positive sentiment is attributed to favorable policies boosting investor confidence, with long-term prospects for stablecoins expected to drive the virtual asset industry [3] Financial Sector Performance - The banking sector showed strong performance, with Qingnong Commercial Bank and Sunong Bank rising over 3%, and several banks reaching historical highs [4] - The People's Bank of China reported an increase in social financing scale and new RMB loans, indicating a robust financial environment [4] - Analysts suggest that bank stocks have strong earnings certainty and recommend focusing on their investment value due to stable fundamentals and low valuations [5] Real Estate Sector Activity - The real estate sector exhibited strong performance, with a 1.69% overall increase, and 81 out of 91 stocks rising [6] - Positive policy signals from the government aim to stabilize the real estate market, with measures to optimize existing policies and enhance market expectations [6][7] - The National Bureau of Statistics indicated that the real estate market is moving towards stabilization, supported by the implementation of various policies [7]

证券代码：601881 证券简称：中国银河 公告编号：2025-045 中国银河证券股份有限公司 2025年度第十三期短期融资券发行结果公告 | 债券名称 | 中国银河证券股份有限公司 | 2025 | 年度第十三期短期融资券 | | --- | --- | --- | --- | | 债券简称 | 25 银河证券 CP013 | 债券流通代码 | 072510107 | | 发行日 | 2025 年 6 月 13 日 | 起息日 | 2025 年 6 月 16 日 | | 到期兑付日 | 2025 年 12 月 16 日 | 期限 | 183 天 | | 计划发行总额 | 40 亿元人民币 | 实际发行总额 | 40 亿元人民币 | | 票面年利率 | 1.64% | 发行价格 | 100 元/百元面值 | 本 期 发 行 短 期 融 资 券 的 相 关 文 件 已 刊 登 在 中 国 货 币 网 （www.chinamoney.com.cn）、上海清算所网站（www.shclearing.com）、 中国债券信息网（www.chinabond.com.cn）。 特此公告。 中国银河证券股份有限公司董事会 ...

Core Insights - Cell and gene therapy (CGT) is currently the most promising development direction in the biopharmaceutical field, entering a phase of result realization [1] - The industry is characterized by a rich pipeline of ongoing research and development, with a continuous increase in market activity and investment [1][2] - The high outsourcing ratio and market concentration in CGT suggest that CXO companies are likely to benefit first [3] Group 1 - CGT is a new generation of precision therapy following small molecule and large molecule targeted therapies, leading a new wave in biopharmaceuticals, divided into cell therapy and gene therapy [1] - CGT has a high clinical success rate and offers long-term efficacy from single treatments, providing new options for difficult-to-treat diseases, with various products like CAR-T, stem cells, TCR-T, and TIL launched recently [1] - The CAR-T cell therapy has been the most groundbreaking in tumor immunotherapy since 2013, with six products approved in China and more potential products expected to launch soon [1][2] Group 2 - The first globally approved TCR-T cell therapy is expected in 2024, with a 43% overall response rate (ORR) for advanced synovial sarcoma, and companies like Xiangxue Pharmaceutical and Northeast Pharmaceutical are leading in this area [2] - Stem cell therapy is a significant branch of regenerative medicine, expanding its treatment scope from leukemia to anti-aging and cardiovascular diseases, with approvals for mesenchymal stem cell therapies in both China and the U.S. in 2024 [2] - Gene therapy primarily targets rare diseases, genetic disorders, and malignant tumors, with Ultragenyx Pharmaceutical submitting a Biologics License Application for a treatment in December 2024 [2] Group 3 - The high outsourcing ratio in CGT, with over 65% penetration in gene therapy compared to 35% in traditional biopharmaceuticals, indicates a greater demand for CXO services due to the complexity and regulatory challenges in the industry [3]

Core Viewpoint - The report outlines the independent financial advisory opinion regarding the stock option and restricted stock incentive plan proposed by Guangdong Tongyu Communication Co., Ltd. for 2025, emphasizing the plan's structure, pricing, and conditions for granting and exercising options and stocks [1][3][5]. Summary by Sections Section 1: Definitions - The report defines key terms related to the incentive plan, including "stock options," "restricted stocks," "grant date," "exercise price," and "waiting period," ensuring clarity in the context of the plan [1][2]. Section 2: Declaration - China Galaxy Securities Co., Ltd. is appointed as the independent financial advisor for the incentive plan, ensuring compliance with relevant laws and regulations [2][3]. Section 4: Main Content of the Incentive Plan - The incentive plan consists of stock options and restricted stocks, with a total number of stock options to be granted being specified, and the plan is approved by the board of directors [5][6]. - The total number of stock options granted will not exceed 10% of the company's total share capital, and no individual recipient will receive more than 1% of the total share capital [6][27]. Section 5: Pricing and Conditions - The exercise price for stock options is set at 11.92 RMB per share, determined through a self-pricing method based on the average trading price of the company's shares prior to the announcement [14][16]. - The grant price for restricted stocks is set at 7.45 RMB per share, also based on the average trading price prior to the announcement [16][17]. Section 6: Grant and Exercise Conditions - The plan specifies conditions under which stock options and restricted stocks can be granted and exercised, including performance targets related to revenue and net profit growth for the years 2025 and 2026 [19][25]. - The performance targets require a minimum revenue growth rate of 15% for 2025 and 32.25% for 2026, based on the previous year's figures [19][25]. Section 7: Target Recipients - The plan targets a total of 242 individuals, including directors, senior management, and key personnel, excluding independent directors and major shareholders [26][27]. - The distribution of stock options and restricted stocks among recipients is detailed, ensuring no individual exceeds the specified limits [27][29].

证券代码：601881 证券简称：中国银河 公告编号：2025-044 中国银河证券股份有限公司（以下简称"本公司"）于 2024 年 12 月 11 日成功发行了中国银河证券股份有限公司 2024 年度第十六期短期融资券（以 下简称"本期短期融资券"），本期短期融资券发行额为人民币 40 亿元，票 面利率为 1.78%，短期融资券期限为 182 天，兑付日期为 2025 年 6 月 11 日。 （ 详 见 本 公 司 于 2024 年 12 月 12 日 刊 登 于 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）的《中国银河证券股份有限公司 2024 年度第十六期短期 融资券发行结果公告》）。 2025 年 6 月 11 日，本公司兑付了本期短期融资券本息共计人民币 4,035,502,465.75 元。 特此公告。 中国银河证券股份有限公司董事会 2025 年 6 月 13 日 中国银河证券股份有限公司 2024年度第十六期短期融资券兑付完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 责任 ...

Group 1: Airline Industry - The airline industry is expected to experience a performance turning point due to favorable conditions in supply and demand, oil prices, and exchange rates [1] - Supply side factors include slow recovery of the supply chain, retirement of old aircraft, insufficient new orders, and impacts from US-China relations, leading to low growth in aircraft introduction over the next 2-3 years [1] - Forecasted industry supply growth (ASK) for 2025-2027 is 6.32%, 4.56%, and 2.26% respectively, while demand remains strong with high passenger load factors and stable ticket prices expected to increase year-on-year [1] Group 2: Construction Machinery Industry - The construction machinery industry is facing short-term pressure on domestic sales and operating rates, but the long-term outlook remains positive due to ongoing demand for equipment replacement and government support [2] - In the first quarter, there was high growth, but May saw a seasonal decline in excavator sales, which aligns with expectations [2] - Exports of construction machinery from January to April showed steady growth, with significant increases in exports to Africa and South America, and a positive performance in exports to Indonesia and Western Europe [2]